These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2887171)

  • 1. Spasmolytic action of the cerebral circulation improver 6,7-dimethoxy-1- (3,4-dimethoxybenzyl)-4-[( 4-(2-methoxyphenyl)-1-piperazinyl]methyl) isoquinoline in isolated canine vessels.
    Yajima T; Takeuchi T; Okada T; Yoshizaki H; Kuwahara T; Koyama K; Nakamura K
    Arzneimittelforschung; 1987 May; 37(5):498-502. PubMed ID: 2887171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calmodulin antagonistic action of the cerebral circulation improver 6,7-dimethoxy-1-(3,4-dimethoxybenzyl)-4- ([4-(2-methoxyphenyl)-1-piperazinyl]methyl)isoquinoline.
    Nakajima T; Okada T; Kuruma I; Yoshizaki H; Satoh T; Kuwahara T; Nakamura K
    Arzneimittelforschung; 1987 Jun; 37(6):674-9. PubMed ID: 2822056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral vasodilating and vasospasmolytic action of the cerebral circulation improver 6,7-dimethoxy-1-(3,4-dimethoxybenzyl)-4-([4-(2-methoxyphenyl)-1- piperazinyl]methyl)isoquinoline in experimental animals.
    Yajima T; Urano T; Nakamura K; Matsuura A; Himori N; Nakamura K
    Arzneimittelforschung; 1987 Apr; 37(4):379-83. PubMed ID: 3606693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonistic and spasmolytic activities of a new 1,5-benzothiazepine derivative in isolated canine and monkey arteries.
    Kikkawa K; Murata S; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):526-31. PubMed ID: 3165267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mode of action of ifenprodil tartrate in isolated canine cerebral and femoral arteries.
    Honda H; Sakai Y
    Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):211-25. PubMed ID: 2883947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
    Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
    Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the new calcium antagonist 2-nitratopropyl-3-nitratopropyl-2,6-dimethyl-4-(3-nitrophe nyl)- 1,4-dihydropyridine-3,5-dicarboxylate on cerebral circulation in dogs.
    Tsuchida K; Yamazaki R; Kaneko K; Aihara H
    Arzneimittelforschung; 1987 Nov; 37(11):1239-43. PubMed ID: 3481545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive effects of the cerebral circulation improver 6,7-dimethoxy-1-(3,4-dimethoxybenzyl)-4-([4-(2-methoxyphenyl)- 1-piperazinyl]methyl)isoquinoline on stroke symptoms in stroke-prone spontaneously hypertensive rats.
    Kuwahara T; Okada T; Nakamura K; Himori N; Yoshizaki H; Matsuura A; Koyama K; Satoh T; Nakamura K
    Arzneimittelforschung; 1987 Jul; 37(7):778-82. PubMed ID: 3675671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethaphan is a direct arterial vasodilator and an alpha-adrenoceptor antagonist.
    Harioka T; Hatano Y; Mori K; Toda N
    Anesth Analg; 1984 Mar; 63(3):290-6. PubMed ID: 6142667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the endothelium-independent and endothelium-dependent contraction in isolated canine cerebral arteries.
    Kanda M; Shirahase H; Wada K; Nakamura S; Matsui H; Fukata F
    Arzneimittelforschung; 1996 Jul; 46(7):663-6. PubMed ID: 8842332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of naphthylmethyl isoquinoline on contraction and calcium flux of rabbit vascular strips in vitro].
    Zhu WZ; Yang YL
    Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):176-9. PubMed ID: 1317988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct vascular actions of epidermal growth factor-urogastrone and transforming growth factor-alpha.
    Gan BS; Hollenberg MD; MacCannell KL; Lederis K; Winkler ME; Derynck R
    J Pharmacol Exp Ther; 1987 Jul; 242(1):331-7. PubMed ID: 3497258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.
    Wong PC; Aldrich PE; Chiu AT; Earl RA; Hart SD; Johnson AL; Ma P; McCall DE; Price WA; Smith RD
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1088-95. PubMed ID: 8099616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methanol-induced contraction of canine cerebral artery and its possible mechanism of action.
    Li W; Altura BT; Altura BM
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):361-8. PubMed ID: 9653067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
    Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference in prostaglandin modulation of arterial and venous smooth muscle responses to bradykinin and norepinephrine.
    Greenberg S; Kadowitz PJ
    Methods Find Exp Clin Pharmacol; 1982; 4(1):7-24. PubMed ID: 6806549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.